Seongnam, South Korea

Hye Suk Hong

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Cj Cheiljedang Corporation. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hye Suk Hong. Retrieved from https://idiyas.com/inventor/hye-suk-hong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hye Suk Hong: Innovator in Pharmaceutical Production

Introduction

Hye Suk Hong is a notable inventor based in Seongnam-si, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the production of adefovir dipivoxil. Her innovative methods have the potential to enhance the efficiency of drug manufacturing processes.

Latest Patents

Hye Suk Hong holds a patent for an improved production method for adefovir dipivoxil. This method is characterized by the use of dimethylsulfoxide as a reaction solvent. The process involves allowing adefovir to react with chloromethylpivalate at a controlled temperature of 30 to 50°C, utilizing dimethylsulfoxide and triethylamine as solvents.

Career Highlights

Hye Suk Hong is associated with CJ Cheiljedang Corporation, where she applies her expertise in pharmaceutical development. Her work has been instrumental in advancing the production techniques for important medications.

Collaborations

Hye Suk Hong collaborates with esteemed colleagues, including Kwang Do Choi and Yong Tack Lee. These partnerships enhance the research and development efforts within her organization.

Conclusion

Hye Suk Hong's contributions to pharmaceutical innovation, particularly through her patent for adefovir dipivoxil production, highlight her role as a key figure in the industry. Her work continues to influence the field of drug manufacturing positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…